(Q40612270)

22 September 2017

Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice (English)

1 reference

22 September 2017

1 reference

6

Gregory J Gores

1 reference

22 September 2017

Ariel E Feldstein

1

1 reference

22 September 2017

Ali Canbay

2

1 reference

22 September 2017

Maria E Guicciardi

3

1 reference

22 September 2017

Hajime Higuchi

4

1 reference

22 September 2017

Steven F Bronk

5

1 reference

22 September 2017

1 December 2003

1 reference

22 September 2017

Journal of Hepatology

1 reference

22 September 2017

39

1 reference

22 September 2017

6

1 reference

22 September 2017

978-983

1 reference

Nonalcoholic fatty liver disease

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900460-4

7 January 2021

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900460-4

7 January 2021

Etiopathogenesis of nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900460-4

7 January 2021

Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900460-4

7 January 2021

Death receptors: signaling and modulation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900460-4

7 January 2021

Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900460-4

7 January 2021

Anti-Fas induces hepatic chemokines and promotes inflammation by an NF-kappa B-independent, caspase-3-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900460-4

7 January 2021

Cholestasis increases tumor necrosis factor-related apoptotis-inducing ligand (TRAIL)-R2/DR5 expression and sensitizes the liver to TRAIL-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900460-4

7 January 2021

Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900460-4

7 January 2021

The bile acid glycochenodeoxycholate induces trail-receptor 2/DR5 expression and apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900460-4

7 January 2021

Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900460-4

7 January 2021

Nonalcoholic steatohepatitis: An expanded clinical entity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900460-4

7 January 2021

Clinical features and natural history of nonalcoholic steatosis syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900460-4

7 January 2021

Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900460-4

7 January 2021

Role of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900460-4

7 January 2021

Effect of fatty acids on glucose production and utilization in man

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900460-4

7 January 2021

Animal models of steatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900460-4

7 January 2021

Leptin, obesity, and liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900460-4

7 January 2021

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900460-4

7 January 2021

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900460-4

7 January 2021

Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900460-4

7 January 2021

Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900460-4

7 January 2021

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900460-4

7 January 2021

Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900460-4

7 January 2021

Parenchymal cell apoptosis as a signal for sinusoidal sequestration and transendothelial migration of neutrophils in murine models of endotoxin and Fas-antibody-induced liver injury

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900460-4

7 January 2021

Caspase 1-independent IL-1β release and inflammation induced by the apoptosis inducer Fas ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900460-4

7 January 2021

RNA interference targeting Fas protects mice from fulminant hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900460-4

7 January 2021

Obesity in the new millennium

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900460-4

7 January 2021

Body-Mass Index and Mortality in a Prospective Cohort of U.S. Adults

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900460-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900460-4

1 reference

7 January 2021

10.1016/S0168-8278(03)00460-4

Identifiers

DOI

1 reference

22 September 2017

1 reference